LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,113
تعداد مقالات10,208
تعداد مشاهده مقاله40,770,674
تعداد دریافت فایل اصل مقاله8,800,274
Meftahi, G H, Pirzad Jahromi, G, Azari, A, Ghaemmaghami, P. (1399). Detection of Active Plaques in Multiple Sclerosis using 3 and 12 Directional Diffusion-weighted Imaging: Comparison with Gadolinium-enhanced MR Imaging. سامانه مدیریت نشریات علمی, 10(6), 737-744. doi: 10.31661/jbpe.v0i0.925
G H Meftahi; G Pirzad Jahromi; A Azari; P Ghaemmaghami. "Detection of Active Plaques in Multiple Sclerosis using 3 and 12 Directional Diffusion-weighted Imaging: Comparison with Gadolinium-enhanced MR Imaging". سامانه مدیریت نشریات علمی, 10, 6, 1399, 737-744. doi: 10.31661/jbpe.v0i0.925
Meftahi, G H, Pirzad Jahromi, G, Azari, A, Ghaemmaghami, P. (1399). 'Detection of Active Plaques in Multiple Sclerosis using 3 and 12 Directional Diffusion-weighted Imaging: Comparison with Gadolinium-enhanced MR Imaging', سامانه مدیریت نشریات علمی, 10(6), pp. 737-744. doi: 10.31661/jbpe.v0i0.925
Meftahi, G H, Pirzad Jahromi, G, Azari, A, Ghaemmaghami, P. Detection of Active Plaques in Multiple Sclerosis using 3 and 12 Directional Diffusion-weighted Imaging: Comparison with Gadolinium-enhanced MR Imaging. سامانه مدیریت نشریات علمی, 1399; 10(6): 737-744. doi: 10.31661/jbpe.v0i0.925

Detection of Active Plaques in Multiple Sclerosis using 3 and 12 Directional Diffusion-weighted Imaging: Comparison with Gadolinium-enhanced MR Imaging

Journal of Biomedical Physics and Engineering
مقاله 53، دوره 10، شماره 6، بهمن و اسفند 2020، صفحه 737-744    اصل مقاله (714.55 K)
نوع مقاله: Original Research
شناسه دیجیتال (DOI): 10.31661/jbpe.v0i0.925
نویسندگان
G H Meftahi1؛ G Pirzad Jahromi* 1؛ A Azari2؛ P Ghaemmaghami3
1PhD, Neuroscience Research Centre, Baqiyatallah University of Medical Sciences, Tehran, Iran
2BSc, Radiology Department, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
3PhD, Biostatistics Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Background: Multiple Sclerosis (MS), distinguished by aggravating the function of central nervous system because of inflammatory demyelination. The most sensitive method for MS diagnosis is Magnetic resonance imaging (MRI). To distinguish inactive and active MS lesions, contrast-enhanced T1-weighted imaging (CE T1WI) is being used as a gold standard. There are some contraindications in gadolinium based contrast agents (GBCAs) usage. Moreover, diffusion-weighted imaging (DWI) can discover diffusion changes involved inflammatory lesions.
Objective: The current research aims at investigating if typical DWI (3 directional) and 12 directional DWI could be a substitute for CE T1WI in order to show active lesions of MS.
Material and Methods: In this cross-sectional study, 138 patients with CNS symptoms were examined. For all patients, along with CE T1WI, 3 & 12 directional DWI were performed. Intraclass correlation coefficient (ICC), receiver operating characteristic (ROC), the sensitivity versus specificity plot and the area under the curve (AUC) were calculated.
Results: There was a contrast enhancement in CE T1WI for 114 patients (82.6%); in addition, hyper-intense lesions on DWI 3 and DWI 12 were shown in 107 (77.5%) and 117 patients (84.7%) in order. Sensitivity, specificity and AUC were 94.7%, 62.5% and 84% for DWI 12. Moreover, the results were 86%, 62.5 and 79% for the sensitivity, specificity and AUC for DWI 3 respectively.
Conclusion: In spite of lower sensitivity of 12 directional DWI compared to CE T1WI, it could be used as a diagnostic sequence in differentiating enhanced lesions from non-enhanced ones when CE-MRI is a worry.
کلیدواژه‌ها
Demyelinating Diseases؛ Magnetic Resonance Imaging؛ Diffusion Tensor Imaging؛ Gadolinium؛ Multiple Sclerosis
سایر فایل های مرتبط با مقاله
مراجع
  1. Cunnusamy K, Baughman EJ, Franco J, Ortega SB, Sinha S, Chaudhary P, et al. Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells. Clin Immunol. 2014;152(1-2):115-26. doi: 10.1016/j.clim.2014.03.005. PubMed PMID: 24657764. PubMed PMCID: PMC4024444.
  2. Goldenberg MM. Multiple sclerosis review. Pharmacy and Therapeutics. 2012;37(3):175-84. PubMed PMID: 22605909. PubMed PMCID: PMC3351877.
  3. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302. doi: 10.1002/ana.22366. PubMed PMID: 21387374. PubMed PMCID: PMC3084507.
  4. Rammohan KW. Cerebrospinal fluid in multiple sclerosis. Ann Indian Acad Neurol. 2009;12(4):246-53. doi: 10.4103/0972-2327.58282. PubMed PMID: 20182572. PubMed PMCID: PMC2824952.
  5. Traboulsee AL, Li DK. The role of MRI in the diagnosis of multiple sclerosis. Adv Neurol. 2006;98:125-46. PubMed PMID: 16400831.
  6. Gajofatto A, Benedetti MD. Treatment strategies for multiple sclerosis: When to start, when to change, when to stop? World J Clin Cases. 2015;3(7):545-55. doi: 10.12998/wjcc.v3.i7.545. PubMed PMID: 26244148. PubMed PMCID: PMC4517331.
  7. Scalfari A, Knappertz V, Cutter G, Goodin DS, Ashton R, Ebers GC. Mortality in patients with multiple sclerosis. Neurology. 2013;81(2):184-92. doi: 10.1212/WNL.0b013e31829a3388. PubMed PMID: 23836941. PubMed PMCID: PMC3770174.
  8. Da Cruz LC, Batista RR, Domingues RC, Barkhof F. Diffusion magnetic resonance imaging in multiple sclerosis. Neuroimaging Clin N Am. 2011;21(1):71-88. doi: 10.1016/j.nic.2011.02.006. PubMed PMID: 21477752.
  9. Simon JH, Bermel RA, Rudick RA. Simple MRI metrics contribute to optimal care of the patient with multiple sclerosis. Am J Neuroradiol. 2014;35(5):831-2. doi: 10.3174/ajnr.A3937. PubMed PMID: 24699092.
  10. Lohrke J, Frenzel T, Endrikat J, Alves FC, Grist TM, Law M, Lee JM, Leiner T, Li KC, Nikolaou K, Prince MR, Schild HH, Weinreb JC, Yoshikawa K, Pietsch H. 25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives. Adv Ther. 2016;33(1):1-28. doi: 10.1007/s12325-015-0275-4. PubMed PMID: 26809251. PubMed PMCID: PMC4735235.
  11. Absinta M, Sati P, Reich DS. Advanced MRI and staging of multiple sclerosis lesions. Nat Rev Neurol. 2016;12(6):358-68. doi: 10.1038/nrneurol.2016.59. PubMed PMID: 27125632. PubMed PMCID: PMC5074769.
  12. ACR Committee on Drugs and Contrast Media. ACR manual on contrast media: Version 9 [Internet]. 2013. [cited 2013 March 21]. Available from: http://aegysgroup.com/wp-content/uploads/2014/03/170675431-2013-Contrast-Media-ACR-v-9.pdf. 
  13. Thomsen HS, Morcos SK, Almén T, Bellin MF, Bertolotto M, Bongartz G, et al. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2013;23(2):307-18. doi: 10.1007/s00330-012-2597-9. PubMed PMID: 22865271.
  14. Le Bihan D, Iima M. Diffusion Magnetic Resonance Imaging: What Water Tells Us about Biological Tissues. PLoS Biol. 2015;13(7):e1002203. doi: 10.1371/journal.pbio.1002203. PubMed PMID: 26204162. PubMed PMCID: PMC4512706.
  15. Lo CP, Kao HW, Chen SY, Chu CM, Hsu CC, Chen YC, et al. Comparison of diffusion-weighted imaging and contrast-enhanced T1-weighted imaging on a single baseline MRI for demonstrating dissemination in time in multiple sclerosis. BMC Neurol. 2014;14:100. doi: 10.1186/1471-2377-14-100. PubMed PMID: 24885357. PubMed PMCID: PMC4036427.
  16. O’Donnell LJ, Westin CF. An introduction to diffusion tensor image analysis. Neurosurg Clin N Am. 2011;22(2):185-96. doi: 10.1016/j.nec.2010.12.004. PubMed PMID: 21435570. PubMed PMCID: PMC3163395.
  17. Ni H, Kavcic V, Zhu T, Ekholm S, Zhong J. Effects of number of diffusion gradient directions on derived diffusion tensor imaging indices in human brain. Am J Neuroradiol. 2006;27(8):1776-81. PubMed PMID: 16971635.
  18. Kingsley PB, Monahan WG. Selection of the optimum b factor for diffusion-weighted magnetic resonance imaging assessment of ischemic stroke. Magn Reson Med. 2004;51(5):996-1001. doi: 10.1002/mrm.20059. PubMed PMID: 15122682.
  19. Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016;15(2):155-63. doi: 10.1016/j.jcm.2016.02.012. PubMed PMID: 27330520. PubMed PMCID: PMC4913118.
  20. Hajian-Tilaki K. Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation. Caspian J Intern Med. 2013;4(2):627-35. PubMed PMID: 24009950. PubMed PMCID: PMC3755824.
  21. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121-7. doi: 10.1002/ana.1032. PubMed PMID: 11456302.
  22. Davoudi Y, Foroughipour M, Torabi R, Layegh P, Matin N, Shoeibi A. Diffusion Weighted Imaging in Acute Attacks of Multiple Sclerosis. Iran J Radiol. 2016;13(2):e21740. doi: 10.5812/iranjradiol.21740. PubMed PMID: 27679697. PubMed PMCID: PMC5035938.
  23. Suzuki M, Kudo K, Sasaki M, Takahashi S, Takahashi J, Fujima N, et al. Detection of active plaques in multiple sclerosis using susceptibility-weighted imaging: comparison with gadolinium-enhanced MR imaging. Magn Reson Med Sci. 2011;10(3):185-92. doi: 10.2463/mrms.10.185. PubMed PMID: 21960001.
  24. Roychowdhury S, Maldjian JA, Grossman RI. Multiple sclerosis: comparison of trace apparent diffusion coefficients with MR enhancement pattern of lesions. Am J Neuroradiol. 2000;21(5):869-74. PubMed PMID: 10815662.
  25. Eisele P, Szabo K, Griebe M, Rossmanith C, Förster A, Hennerici M, et al. Reduced diffusion in a subset of acute MS lesions: a serial multiparametric MRI study. Am J Neuroradiol. 2012;33(7):1369-73. doi: 10.3174/ajnr.A2975. PubMed PMID: 22576893.
  26. Rosso C, Remy P, Creange A, Brugieres P, Cesaro P, Hosseini H. Diffusion-weighted MR imaging characteristics of an acute strokelike form of multiple sclerosis. Am J Neuroradiol. 2006;27(5):1006-8. PubMed PMID: 16687533.
  27. Rigby H, Maloney W, Bhan V. Diagnostic considerations in acute MS lesions with restricted diffusion on MRI. Can J Neurol Sci. 2012;39(4):525-6. doi: 10.1017/s0317167100014074. PubMed PMID: 22728863.
  28. Balashov KE, Aung LL, Dhib-Jalbut S, Keller IA. Acute multiple sclerosis lesion: conversion of restricted diffusion due to vasogenic edema. J Neuroimaging. 2011;21(2):202-4. doi: 10.1111/j.1552-6569.2009.00443.x. PubMed PMID: 19888931. PubMed PMCID: PMC2891920.
  29. Narayana PA, Zhou Y, Hasan KM, Datta S, Sun X, Wolinsky JS. Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis. Mult Scler. 2014;20(3):365-73. doi: 10.1177/1352458513495936. PubMed PMID: 23836878. PubMed PMCID: PMC3844029.
  30. Rovira A, Auger C, Alonso J. Magnetic resonance monitoring of lesion evolution in multiple sclerosis. Ther Adv Neurol Disord. 2013;6(5):298-310. doi: 10.1177/1756285613484079. PubMed PMID: 23997815. PubMed PMCID: PMC3755529.
  31. Yurtsever I, Hakyemez B, Taskapilioglu O, Erdogan C, Turan OF, Parlak M. The contribution of diffusion-weighted MR imaging in multiple sclerosis during acute attack. Eur J Radiol. 2008;65(3):421-6. doi: 10.1016/j.ejrad.2007.05.002. PubMed PMID: 17587524.
 

آمار
تعداد مشاهده مقاله: 1,972
تعداد دریافت فایل اصل مقاله: 422


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب